Products & ReviewClinical Diagnostics
COVID-19 Ag + FLU A&B
The FREND™ COVID-19 Ag + Flu A&B is a fluorescence immunoassay (FIA) for use with the FREND™ System?. It is designed for the qualitative and simultaneous detection of the nucleocapsid protein of SARS-CoV-2 and Influenza A&B virus. It measures directly from nasopharyngeal swab specimens.
Request Pricing
Receive your quote directly from the manufacturer.
KEY FEATURES & BENEFITS
- 3 minutes | Fast result
- 2 steps | Easy to use
- Microfluidic Qualitative Immunoassay
- LIS connectivity (data management)
- COVID-19 Ag | 95.56 % & 99.66% Percent Agreement
- Influenza A | 100.00 % & 99.67 % Percent Agreement
- Influenza B | 97.50 % & 98.66 % Percent Agreement
